Technical Analysis for ARKG - ARK Genomic Revolution Multi-Sector ETF

Grade Last Price % Change Price Change
grade C 27.25 -2.43% -0.68
ARKG closed down 2.43 percent on Friday, December 14, 2018, on 1.54 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
4 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ARKG trend table...

Date Alert Name Type % Chg
Dec 14 Stochastic Reached Oversold Weakness 0.00%
Dec 14 Oversold Stochastic Weakness 0.00%
Dec 13 20 DMA Resistance Bearish -2.43%
Dec 12 20 DMA Resistance Bearish -4.69%
Dec 12 50 DMA Resistance Bearish -4.69%
Dec 12 Gapped Up Strength -4.69%
Dec 12 Up 3 Days in a Row Strength -4.69%
Dec 11 Pocket Pivot Bullish Swing Setup -3.37%
Dec 10 MACD Bearish Signal Line Cross Bearish -2.85%
Dec 7 20 DMA Resistance Bearish -2.33%

Older signals for ARKG ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
Basic chart:

Profile
The investment seeks long-term growth of capital. The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
Is ARKG a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Dec 13 Senate Dems introduce bill to block "excessive" increases in drug prices
Dec 4 An ETF to Capture Biotech’s Breakthrough of the Century
Dec 3 The Power of Genome Editing: What Investors Should Know
Dec 3 Trump cabinet members submit plan on reforming U.S. healthcare
Nov 28 Biotechs could face cash crunch next year - Leerink
Nov 19 Another Fintech ETF is Coming
Nov 12 3 DNA Stocks That Are on the Uptrend
Oct 31 Biotech IPOs on pace for near-record year - WSJ
Oct 30 FDA announces action plan to advance innovation in plant and animal biotech
Oct 26 Trump mulling tieing U.S. drug prices to Europe's
See more ARKG news...
Indicators
Indicator Value
52 Week High 34.69
52 Week Low 24.0
Average Volume 139,288
200-Day Moving Average 29.3588
50-Day Moving Average 28.7718
20-Day Moving Average 28.6495
10-Day Moving Average 28.638
Average True Range 0.9849
ADX 16.87
+DI 21.4276
-DI 34.3349
Chandelier Exit (Long, 3 ATRs ) 27.8853
Chandelier Exit (Short, 3 ATRs ) 29.8847
Upper Bollinger Band 30.3302
Lower Bollinger Band 26.9688
Percent B (%b) 0.08
BandWidth 11.73284
MACD Line -0.3051
MACD Signal Line -0.1625
MACD Histogram -0.1426
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 28.54
Resistance 3 (R3) 28.63 28.30 28.33
Resistance 2 (R2) 28.30 27.97 28.25 28.25
Resistance 1 (R1) 27.77 27.77 27.61 27.68 28.18
Pivot Point 27.44 27.44 27.35 27.39 27.44
Support 1 (S1) 26.91 27.11 26.75 26.82 26.32
Support 2 (S2) 26.58 26.91 26.53 26.25
Support 3 (S3) 26.05 26.58 26.18
Support 4 (S4) 25.96